Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations

Cancer treatment and survivorship statistics, 2016

Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text

Medicine, Oncology, Population Health Sciences +17

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

Karel G.M. Moons, Douglas G. Altman, Johannes B. Reitsma et al. · Annals of Internal Medicine · 2015 · 5.2K citations · Full text

Computing, Biostatistics, Clinical Decision Support +14

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

Medicine, Oncology, Pharmacology +12

A note on quantifying follow-up in studies of failure time

M. Schemper, Terry L. Smith · Controlled Clinical Trials · 1996 · 2.5K citations

Public Health, Biostatistics, Survival Analysis +7

Genomic spectra of biliary tract cancer

Hiromi Nakamura, Yasuhito Arai, Yasushi Totoki et al. · Nature Genetics · 2015 · 1.3K citations

Medicine, Genetics, Molecular Genetics +14